Literature DB >> 21917055

Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype.

Ayesha B Alvero1, Michele K Montagna, Vinicius Craveiro, Lanzhen Liu, Gil Mor.   

Abstract

PROBLEM: Presence of immune infiltrates in the tumor does not always correlate with an anti-tumoral immune response. We previously identified two subpopulations of epithelial ovarian cancer (EOC) cells with differential cytokine profile. We hypothesize that these two subpopulations of EOC cells may differentially regulate the immune phenotype in the tumor microenvironment and therefore affect the immune response. METHOD OF STUDY: Macrophages derived from CD14+ monocytes and naive CD4+T cells were treated with conditioned media from two subpopulations of EOC cells. Differentiation markers and phagocytic activity were measured by western blot analysis and flow cytometry. Cytokine levels were quantified using xMAP technology.
RESULTS: Type I EOC cells are able to enhance macrophages' capacity for tumor repair and renewal by enhancing expression of scavenger receptors and by promoting the secretion of cytokines associated with tissue repair. On the other hand, type II EOC cells are able to create a tolerant microenvironment and prevent an immune response by inducing macrophages' to secrete IL-10 and by promoting the generation of T regs.
CONCLUSION: We demonstrate that each ovarian cancer cell subpopulation can induce a unique phenotype of macrophages and T cells, both associated with tumor-supportive function.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917055      PMCID: PMC3707144          DOI: 10.1111/j.1600-0897.2011.01068.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  38 in total

Review 1.  Alternative versus classical activation of macrophages.

Authors:  S Goerdt; O Politz; K Schledzewski; R Birk; A Gratchev; P Guillot; N Hakiy; C D Klemke; E Dippel; V Kodelja; C E Orfanos
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

Review 2.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

Review 3.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

Review 4.  Macrophages and apoptotic cell clearance during pregnancy.

Authors:  Vikki M Abrahams; Yeon Mee Kim; Shawn L Straszewski; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2004-04       Impact factor: 3.886

Review 5.  Cytokines and macrophages.

Authors:  J M Cavaillon
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529

6.  M-1/M-2 macrophages and the Th1/Th2 paradigm.

Authors:  C D Mills; K Kincaid; J M Alt; M J Heilman; A M Hill
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

7.  Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.

Authors:  Marijke Kamsteeg; Thomas Rutherford; Eva Sapi; Bozena Hanczaruk; Shoreh Shahabi; Maryann Flick; David Brown; Gil Mor
Journal:  Oncogene       Date:  2003-05-01       Impact factor: 9.867

8.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

9.  Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer.

Authors:  Tyler J Curiel; Pui Cheng; Peter Mottram; Xavier Alvarez; Lieve Moons; Melina Evdemon-Hogan; Shuang Wei; Linhua Zou; Ilona Kryczek; Gary Hoyle; Andrew Lackner; Peter Carmeliet; Weiping Zou
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

10.  Epithelial ovarian cancer cells secrete functional Fas ligand.

Authors:  Vikki M Abrahams; Shawn L Straszewski; Marijke Kamsteeg; Bozena Hanczaruk; Peter E Schwartz; Thomas J Rutherford; Gil Mor
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

View more
  20 in total

1.  Effect of culture conditions on the phenotype of THP-1 monocyte cell line.

Authors:  Paulomi B Aldo; Vinicius Craveiro; Seth Guller; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2013-04-29       Impact factor: 3.886

2.  Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers.

Authors:  Devin C Koestler; Carmen J Marsit; Brock C Christensen; William Accomando; Scott M Langevin; E Andres Houseman; Heather H Nelson; Margaret R Karagas; John K Wiencke; Karl T Kelsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-19       Impact factor: 4.254

3.  TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.

Authors:  Ilana Chefetz; Ayesha B Alvero; Jennie C Holmberg; Noah Lebowitz; Vinicius Craveiro; Yang Yang-Hartwich; Gang Yin; Lisa Squillace; Marta Gurrea Soteras; Paulomi Aldo; Gil Mor
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

4.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Trophoblast induces monocyte differentiation into CD14+/CD16+ macrophages.

Authors:  Paulomi B Aldo; Karen Racicot; Vinicius Craviero; Seth Guller; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-07-03       Impact factor: 3.886

6.  Involvement of autophagy in ovarian cancer: a working hypothesis.

Authors:  Claudia Peracchio; Oscar Alabiso; Guido Valente; Ciro Isidoro
Journal:  J Ovarian Res       Date:  2012-09-13       Impact factor: 4.234

7.  The duplicitous origin of ovarian cancer.

Authors:  Gil Mor; Ayesha Alvero
Journal:  Rambam Maimonides Med J       Date:  2013-01-30

8.  Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model.

Authors:  Andrew J Wilson; Whitney Barham; Jeanette Saskowski; Oleg Tikhomirov; Lianyi Chen; Hye-Jeong Lee; Fiona Yull; Dineo Khabele
Journal:  J Ovarian Res       Date:  2013-09-10       Impact factor: 4.234

Review 9.  The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer.

Authors:  Dineo Khabele
Journal:  Front Oncol       Date:  2014-05-20       Impact factor: 6.244

Review 10.  TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis.

Authors:  Sudhakar V Nuti; Gil Mor; Peiyao Li; Gang Yin
Journal:  Oncotarget       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.